About the Company
We do not have any company description for Nautilus Biotechnology, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
170
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) Q1 2024 Earnings Conference Call April 30, 2024 8:30 AM ET Company Participants Sujal Patel - Co-Founder & Chief Executive Officer ...
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2023 Earnings Conference Call February 28, 2024 8:30 AM ETCompany ParticipantsCarrie Mendivil - IRSujal Patel ...
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 ...
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported ...
Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You ... - Nasdaq
Nautilus Biotechnology, Inc. (NAUT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported ...
Nautilus Biotechnology to Announce Second Quarter 2025 ... - FOX40
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the ...
Nautilus Biotechnology Inc.: Nautilus Biotechnology Reports Second ...
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule proteome analysis platform, today reported financial ...
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call ...
Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.00015, expectations were $-0.16. - All Parts ...
Nautilus Biotechnology to Announce Second Quarter 2025 Financial ...
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the ...
Similar Companies
Loading the latest forecasts...